Signs, Symptoms, and the Clinical Spectrum
At a Glance
CLN12 disease is an ATP13A2-related neurological condition with symptoms that vary widely. Movement, thinking, eye-movement, seizure, nerve, and swallowing problems can occur; sudden changes or severe breathing, swallowing, or seizure emergencies need prompt care.
Because ATP13A2-related disease exists on a spectrum, the symptoms can vary significantly from one person to another. Doctors often use different names based on which symptoms appear first and at what age [1]. Some people may primarily experience walking difficulties, while others may first notice tremors or changes in how they think and feel [2].
Movement and Physical Symptoms
Movement challenges are a hallmark of this condition, though they can manifest in several different ways depending on which parts of the nervous system are most affected [3].
- Parkinsonism: This includes a group of symptoms similar to Parkinson’s disease, such as bradykinesia (slow movement), muscle rigidity (stiffness), and resting tremors [2][1]. These often appear in childhood or adolescence in the Kufor-Rakeb form [4].
- Spasticity: This refers to muscle stiffness and “tightness” that can make limbs, especially the legs, difficult to move. This is the primary feature of the SPG78 form and can lead to a “stiff” or “scissors-like” walking pattern [1][5].
- Dystonia: Involuntary muscle contractions that cause repetitive movements or unusual postures. This might look like a foot turning inward or the neck pulling to one side [2].
- Myoclonus: Brief, shock-like jerks of a muscle or group of muscles [6].
- Ataxia: A lack of muscle coordination that can cause clumsiness, instability, or an unsteady, wide-based gait [2].
Cognitive and Psychiatric Changes
Changes in thinking and mood are reported in some people with ATP13A2-related conditions. These symptoms may emerge before or after the physical movement changes, but they are not inevitable for everyone [7][8].
- Cognitive Decline: This can range from mild learning difficulties and intellectual disability in childhood to progressive dementia later in life [7][9]. It may affect memory, problem-solving, and the ability to plan daily tasks [10].
- Psychiatric Symptoms: Some individuals experience psychosis, which may include paranoid thoughts or hallucinations (seeing or hearing things that aren’t there) [2][11]. Sudden confusion or psychosis should be checked promptly for treatable causes like infections or medication side effects.
- Behavioral Features: Behavioral outbursts, high levels of agitation, or features similar to autism spectrum disorder have also been reported [2][12].
Other Neurological Signs
The “spectrum” nature of this disease means other parts of the body and brain may be involved:
- Eye Movement Issues: A classic sign, especially in Kufor-Rakeb, is supranuclear gaze palsy. This makes it difficult to move the eyes up or down [2][10].
- Seizures: Recurrent seizures are documented in some patients and may require specialized medication management [6][5].
- Peripheral Neuropathy: Some people experience numbness, tingling, or weakness in their hands and feet due to damage to the nerves outside the brain and spinal cord [1][5].
- Speech and Swallowing: Difficulty speaking (dysarthria) or swallowing (dysphagia) can occur as the muscles involved in these actions become stiff or weak [3][10].
Using a one-page symptom and medication tracker, including falls, choking with meals, sleep, hallucinations, and seizures, can help you share this information with your doctors.
Managing Symptoms vs. Emergencies
Living with a progressive neurological condition means learning to distinguish between symptoms that are part of your “new normal” and those that require immediate medical attention.
What is generally NOT an emergency:
- A steady, long-term tremor or muscle stiffness.
- Slow movement or a baseline level of forgetfulness.
- Occasional, mild clumsiness that hasn’t changed recently.
These should be discussed with your neurologist during your regular appointments.
Requires prompt OUTPATIENT or same-day assessment:
- A wet voice, coughing with meals, or recurrent chest infections should prompt rapid medical and swallowing evaluation.
- Sudden confusion, psychosis, or loss of walking needs urgent assessment for treatable causes like infection, stroke, or medication effects.
Requires EMERGENCY services (Call 911):
While this condition progresses with a variable rate, certain situations require prompt intervention:
- Severe Swallowing Issues: Complete airway obstruction, cyanosis (blue lips), or severe breathing difficulty. This can lead to aspiration (food or liquid entering the lungs) [13][14].
- Uncontrolled Seizures: A first-time seizure, any seizure that lasts longer than five minutes, or multiple seizures in a row without waking up in between, is a medical emergency (status epilepticus) [15].
- Sudden Changes: Sudden stroke-like symptoms (e.g., facial drooping, sudden severe weakness) should be evaluated immediately by a doctor.
Common questions in this guide
What symptoms are common in CLN12 disease?
How can Kufor-Rakeb syndrome and SPG78 look different?
Which CLN12 symptoms need urgent medical attention?
How do I know if swallowing is becoming a problem?
What should I record in a CLN12 symptom tracker?
Can CLN12 disease affect thinking or behavior?
Get notified when new evidence is published on CLN12 disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
Estrada-Cuzcano A, Martin S, Chamova T, et al.
Brain : a journal of neurology 2017; (140(2)):287-305 doi:10.1093/brain/aww307.
PMID: 28137957 - 2
Psychiatric Manifestations of ATP13A2 Mutations.
Balint B, Damasio J, Magrinelli F, et al.
Movement disorders clinical practice 2020; (7(7)):838-841 doi:10.1002/mdc3.13034.
PMID: 33033738 - 3
Motor Neuron Involvement in Two ATP13A2-Related Families: ALS And HSP-Like Phenotypes.
Khosravi S, Amini E, Emamikhah M, et al.
Movement disorders clinical practice 2025; (12(6)):852-857 doi:10.1002/mdc3.70027.
PMID: 40028680 - 4
Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
Park JS, Sue CM
Current protein & peptide science 2017; (18(7)):725-732 doi:10.2174/1389203717666160311121534.
PMID: 26965689 - 5
A novel ATP13A2 variant causing complicated hereditary spastic paraplegia.
Zhang F, Liu P, Li J, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(4)):1749-1753 doi:10.1007/s10072-024-07334-w.
PMID: 38252374 - 6
Action Myoclonus and Seizure in Kufor-Rakeb Syndrome.
Rohani M, Lang AE, Sina F, et al.
Movement disorders clinical practice 2018; (5(2)):195-199 doi:10.1002/mdc3.12570.
PMID: 30868101 - 7
Case Report: Novel ATP13A2 pathogenic variants associated with early-onset parkinsonism and a mini-review.
Affronte L, Pini A, Pizzoli C, et al.
Frontiers in genetics 2025; (16()):1588812 doi:10.3389/fgene.2025.1588812.
PMID: 40799219 - 8
Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype.
Estiar MA, Leveille E, Spiegelman D, et al.
Molecular genetics & genomic medicine 2020; (8(3)):e1052 doi:10.1002/mgg3.1052.
PMID: 31944623 - 9
Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia.
Odake Y, Koh K, Takiyama Y, et al.
Neurology. Genetics 2020; (6(5)):e514 doi:10.1212/NXG.0000000000000514.
PMID: 33134512 - 10
Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
Pietrzak A, Badura-Stronka M, Kangas-Kontio T, et al.
Folia neuropathologica 2019; (57(3)):285-294 doi:10.5114/fn.2019.88459.
PMID: 31588715 - 11
Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy.
Colijn MA, Vrijsen S, Au PYB, et al.
Neurogenetics 2024; (25(4)):405-415 doi:10.1007/s10048-024-00767-7.
PMID: 39023817 - 12
Successful treatment of psychosis in a patient with Kufor-Rakeb syndrome with low dose aripiprazole: a case report.
McNeil-Gauthier AL, Brais B, Rouleau G, et al.
Neurocase 2019; (25(3-4)):133-137 doi:10.1080/13554794.2019.1625928.
PMID: 31232173 - 13
Aspiration and silent aspiration in Niemann-Pick disease type C1: longitudinal findings from the NIH natural history study.
Solomon BI, Munoz AM, Borruso A, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42693440 - 14
Long-term outcomes after surgery to prevent aspiration for patients with amyotrophic lateral sclerosis.
Soga T, Suzuki N, Kato K, et al.
BMC neurology 2022; (22(1)):94 doi:10.1186/s12883-022-02619-z.
PMID: 35296264 - 15
Dantrolene paradoxically exacerbates short-term brain glucose hypometabolism, hippocampal damage and neuroinflammation induced by status epilepticus in the rat lithium-pilocarpine model.
García-García L, Gómez-Oliver F, Fernández de la Rosa R, Pozo MÁ
European journal of pharmacology 2024; (985()):177073 doi:10.1016/j.ejphar.2024.177073.
PMID: 39481630
This page is for informational purposes only and does not constitute medical advice. Ask your neurologist about ongoing symptoms, and call emergency services for severe breathing or swallowing problems, prolonged seizures, or sudden stroke-like changes.